These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8923326)

  • 1. Optimization of the formulation design of chitosan microspheres containing cisplatin.
    Wang YM; Sato H; Adachi I; Horikoshi I
    J Pharm Sci; 1996 Nov; 85(11):1204-10. PubMed ID: 8923326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on preparation and characteristics of cisplatin chitosan microspheres].
    Wang YM; Shi TS; Pu YL; Zhu JG; Zhao YL
    Yao Xue Xue Bao; 1996; 31(4):300-5. PubMed ID: 9208650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release characteristics of cisplatin chitosan microspheres and effect of containing chitin.
    Nishioka Y; Kyotani S; Okamura M; Miyazaki M; Okazaki K; Ohnishi S; Yamamoto Y; Ito K
    Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2871-3. PubMed ID: 2076575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on hepatic arterial embolization with cisplatin-chitosan-microspheres in dogs].
    Wang YM; Shi TS; Pu YL; Zhu JG; Zhao YL
    Yao Xue Xue Bao; 1995 Dec; 30(12):891-5. PubMed ID: 8712014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of embolizing materials for chemo-embolization therapy of hepatocellular carcinoma: embolic effect of cisplatin albumin microspheres using chitin and chitosan in dogs, and changes of cisplatin content in blood and tissue.
    Nishioka Y; Kyotani S; Okamura M; Miyazaki M; Sakamoto Y; Morita M; Okazaki K; Ohnishi S; Yamamoto Y; Ito K
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):267-8. PubMed ID: 1576685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and release characteristics of cisplatin albumin microspheres containing chitin and treated with chitosan.
    Nishioka Y; Kyotani S; Masui H; Okamura M; Miyazaki M; Okazaki K; Ohnishi S; Yamamoto Y; Ito K
    Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3074-7. PubMed ID: 2632057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of formulation variables on cis-platin loaded chitosan microsphere properties.
    Akbuğa J; Bergişadi N
    J Microencapsul; 1999; 16(6):697-703. PubMed ID: 10575622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release of interleukin-2 from chitosan microspheres.
    Ozbaş-Turan S; Akbuğa J; Aral C
    J Pharm Sci; 2002 May; 91(5):1245-51. PubMed ID: 11977100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of magnesium stearate on chitosan microspheres prepared by an emulsification-coacervation technique.
    Lim LY; Wan LS
    J Microencapsul; 1998; 15(3):319-33. PubMed ID: 9608395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation optimization of chelerythrine loaded O-carboxymethylchitosan microspheres using response surface methodology.
    Li GY; Zhong M; Zhou ZD; Zhong YD; Ding P; Huang Y
    Int J Biol Macromol; 2011 Dec; 49(5):970-8. PubMed ID: 21889529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of embolizing materials for chemo-embolization therapy of hepatocellular carcinoma: effects of particle size and dose on chitin-containing cis-diamminedichloroplatinum(II) albumin microsphere antitumor activity in VX2 hepatic tumor model rabbits.
    Nishioka Y; Kyotani S; Okamura M; Ohnishi S; Yamamoto Y; Kawashima Y; Tanada S; Nakamura T
    Biol Pharm Bull; 1994 Sep; 17(9):1251-5. PubMed ID: 7841948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microspheres of alginate-chitosan containing isoniazid.
    Lucinda-Silva RM; Evangelista RC
    J Microencapsul; 2003; 20(2):145-52. PubMed ID: 12554370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of cross-linked chitosan microspheres for drug delivery applications.
    Dini E; Alexandridou S; Kiparissides C
    J Microencapsul; 2003; 20(3):375-85. PubMed ID: 12881117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole.
    Hassan EE; Parish RC; Gallo JM
    Pharm Res; 1992 Mar; 9(3):390-7. PubMed ID: 1614973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of sustained release cross-linked chitosan microspheres containing phenobarbitone.
    al-Helw AA; Al-Angary AA; Mahrous GM; al-Dardari MM
    J Microencapsul; 1998; 15(3):373-82. PubMed ID: 9608399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different molecular weight chitosan microspheres: influence on drug loading and drug release.
    Genta I; Perugini P; Pavanetto F
    Drug Dev Ind Pharm; 1998 Aug; 24(8):779-84. PubMed ID: 9876526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of process parameters involved in chitosan microsphere preparation by the o/w/o multiple emulsion method.
    Pavanetto F; Perugini P; Conti B; Modena T; Genta I
    J Microencapsul; 1996; 13(6):679-88. PubMed ID: 8933353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-stage optimization process for formulation of chitosan microspheres.
    Dubey RR; Parikh RH
    AAPS PharmSciTech; 2004 Feb; 5(1):E5. PubMed ID: 15198526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation and characterization of cisplatin-loaded poly(benzyl l-glutamate) microspheres for chemoembolization.
    Li C; Yang DJ; Nikiforow S; Tansey W; Kuang LR; Wright KC; Wallace S
    Pharm Res; 1994 Dec; 11(12):1792-9. PubMed ID: 7534920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and drug release properties of norisoboldine-loaded chitosan microspheres.
    He M; Wang H; Dou W; Chou G; Wei X; Wang Z
    Int J Biol Macromol; 2016 Oct; 91():1101-9. PubMed ID: 27344949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.